Measured Wealth Private Client Group’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$233K Sell
9,480
-11,368
-55% -$263K 0.06% 185
2026
Q1
$499K Buy
20,848
+3,401
+19% +$83.1K 0.14% 104
2025
Q4
$395K Buy
+17,447
New +$380K 0.1% 120

Other funds holding ELAN

Measured Wealth Private Client Group's ELAN Position: Q2 2026 in Review

Measured Wealth Private Client Group reduced its Elanco Animal Health (ELAN) stake by 55% in Q2 2026, selling an estimated $263K and leaving 9,480 shares worth $233K. The position accounts for 0.06% of the portfolio, ranked #185.

Measured Wealth Private Client Group first reported a position in ELAN in Q4 2025 and has held it in 3 quarters since. The position peaked at $499K in Q1 2026. 522 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Measured Wealth Private Client Group held 9,480 shares of Elanco Animal Health worth $233K as of Q2 2026.
  • Measured Wealth Private Client Group sold 11,368 Elanco Animal Health shares in Q2 2026, an estimated $263K.
  • Elanco Animal Health made up 0.06% of Measured Wealth Private Client Group's portfolio in Q2 2026, its #185 holding.
  • Measured Wealth Private Client Group first reported a position in Elanco Animal Health in Q4 2025 and has held it in 3 quarters since.
  • Measured Wealth Private Client Group's Elanco Animal Health position peaked at $499K in Q1 2026.
  • 522 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Measured Wealth Private Client Group's 13F filing for Q2 2026, filed 10 Aug 2026.